Whilep16Ink4a is a cyclin-dependent kinase inhibitor (CKI) that functions upstream of Rb1,Arf exerts its tumor suppressor function by responding to inappropriate Rb pathwaysignaling above a presumed threshold (Lowe and Sherr,2003). Here, CDKN2A is linked to neoplasm.